MedPath

An observational study to obtain normal values of inflammatory variables in induced sputum, exhaled breath, and bronchial biopsies from healthy smoking and non-smoking individuals

Completed
Conditions
Asthma
COPD
emphysema
10006436
Registration Number
NL-OMON33652
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

1. Doctor*s diagnosis of normal pulmonary health
2. Post bronchodilator FEV1/FVC >70%
3. PC20 methacholine >12 mg/ml
4. Reversibility of FEV1% predicted <10%

Exclusion Criteria

1. Persons who used inhaled or oral corticosteroids during >5 years, or
within the last 5 years.
2. FEV1 <1.2 L,
3. A subject is not eligible to enter and participate if he does not agree
that we inform his general practicioner about participation in the study and also
about any unexpected finding during the study.
4. Upper respiratory tract infection (e.g. colds), within 2 months.
5. Pregnancy, or the possibility of being pregnant (i.e. women who do not use adequate anticonception as judged by the investigator).
6. Malignancy within the past 5 years (except for squamous or basal cell carcinoma
of the skin that has been treated with no evidence of recurrence).
7. Signs or symptoms of any other concomitant disease that, in the eyes of the
investigator, can interfere with the study results.
8. Known recent substance abuse (drug or alcohol).
9. Claustrophobia

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Parameters for airway inflammation and remodeling in bronchial biopsies. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Parameters for airway inflammation in sputum and blood.<br /><br>HRCT scan<br /><br>symptoms<br /><br>Lung function </p><br>
© Copyright 2025. All Rights Reserved by MedPath